Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

The Leukemia & Lymphoma Society Welcomes Five Members to its Board of Directors

Leukemia & Lymphoma Society logo (PRNewsfoto/The Leukemia & Lymphoma Society)

News provided by

The Leukemia & Lymphoma Society (LLS)

Jul 01, 2024, 09:30 ET

Share this article

Share toX

Share this article

Share toX

New Members Include Hematologists, NFL Vet, Operations & Communications Executives; All-Woman Executive Committee Named

RYE BROOK, N.Y., July 1, 2024 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) named five new members to its board of directors effective July 1, 2024, whose diverse experience and interests will be instrumental in helping the organization carry out its mission to cure blood cancer and improve the quality of life of all patients and their families.

LLS proudly welcomes the following new members to its board:

Dr. Sharon Castellino
Dr. Sharon Castellino
Mike Farmer
Mike Farmer
Alex Okafor
Alex Okafor
Dr. Rayne Rouce
Dr. Rayne Rouce
Lilian Stern
Lilian Stern

Sharon Castellino, M.D., MSc: Dr. Castellino is a Professor of Pediatrics at Emory University School of Medicine, where she serves as the Director of the Leukemia and Lymphoma Program and as the Mark R. Hudgens Chair for Clinical Research in the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta. She is the founder and co-leader of the leukemia and lymphoma biorepository, vice chair for the pediatric oncology precision medicine protocol at CHOA, and a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute at Emory University. Nationally, Dr. Castellino serves as the Scientific Chair for the Children's Oncology Group (COG) Hodgkin Lymphoma Committee. She has led several seminal clinical trials for children, adolescents, and young adults with Hodgkin lymphoma and has been a leader in creating models for collaborative research to benefit children and adolescents. Dr. Castellino also has expertise in healthcare delivery research, particularly as it relates to adolescents, young adults, and under-represented patients.

Mike Farmer: Mr. Farmer was formerly President of commercial operations at Builders FirstSource. He led the company's commercial efforts, including sales and national accounts, marketing, customer segment strategy, and innovation. In this role, Mr. Farmer was responsible for leading the implementation of commercial operations best practices to create sustainable growth and drive innovation through best-in-class manufacturing capabilities in components, millwork, and READY-FRAME®, while providing an exceptional customer experience. Mr. Farmer has been an influential volunteer for LLS for many years.

Alex Okafor: Mr. Okafor is a retired nine-year NFL vet and 2020 Super Bowl Champion with the Kansas City Chiefs. In 2021, he helped launch LLS's Scholarship for Blood Cancer Survivors, which he continues to sponsor through his Family Foundation and supports by giving his time to aspects of the program and other LLS initiatives. Mr. Okafor is active in his community and currently serves on the Pflugerville Independent School District Board of Trustees.

Rayne H. Rouce, M.D.: Dr. Rouce is a board-certified pediatric hematologist/oncologist at Texas Children's Cancer Center at Baylor College of Medicine (BCM), where she is also a physician-scientist. Her clinical and research interests are harnessing the immune system to target leukemia and lymphoma. Dr. Rouce has served as the Pediatric Clinical Cell Therapy Lead, Co-Director of the Immunotherapy Fellowship, and principal investigator on numerous first-in-human immunotherapy trials targeting leukemia and lymphoma. Passionate about addressing health disparities and access to novel treatments and trials, she leads the Task Force for Promoting Equity in Clinical Trials within the Dan L Duncan Comprehensive Cancer Center at BCM. Dr. Rouce supports health equity initiatives within medicine in general and cancer specifically by serving as the Director of Community Outreach and Engagement within BCM's Office of Community Engagement and Health Equity and as the Associate Director of Community Outreach and Engagement for the Dan L Duncan Comprehensive Cancer Center. She also leads DEI programs for scientific organizations such as ASH, ASGCT, and ASTCT. Dr. Rouce actively presents, advocates, and participates in collaborative groups tackling health disparities and cancer-related equity issues.   

Lilian Stern: Ms. Stern is Principal of Stern Investor Relations, Inc., a consulting firm she founded more than 20 years ago, which specializes in investor relations services for biotechnology companies. The firm has represented hundreds of public and private companies, more than 30% of which are working on novel oncology therapies. Throughout Stern IR's history, Ms. Stern has committed to the key value of contributing to human health by facilitating capital into the industry.   

"Our new members have demonstrated in so many ways their steadfast commitment to curing blood cancer and improving the quality of life of all patients and their families," said E. Anders Kolb, M.D., President and CEO of LLS. "Having a more inclusive board has been a priority for LLS, and our new members reflect the diverse needs of the communities we serve. We are fortunate to benefit from their unique expertise as we work together to help patients thrive through treatment and beyond."

LLS's new board members will serve under the newly appointed Board Chair, Alessandra Tocco. She heads an all-woman executive committee of officers comprised of existing members: Freda Wang, Vice Chair (former Secretary-Treasurer); Marla Persky, Secretary-Treasurer; and Janice L. Gabrilove, M.D., Director-At-Large. 

Members continuing to serve on LLS's board include: Rich Bagger, Leroy M. Ball, Mark J. Barrenechea, Renzo Canetta, MD, Casey Cunningham, M.D., Jennifer Marley, Ari Melnick, M.D., Kathleen Meriwether, Ruben A. Mesa, M.D., FACP, Lynn F. O'Brien, Jim Reddoch, Ph.D., Richard M. Rendina, Robert Rosen, Jeff Sachs, Yvette Tremonti. Bart Sichel has exited the board and completed his term on June 30, 2024.

To learn more about LLS's Board of Directors, please visit this link.

Journalists and reporters seeking additional information, please contact [email protected]. 

About The Leukemia & Lymphoma Society (LLS)
The Leukemia & Lymphoma Society® (LLS) is the global leader in the fight against blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease, and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

Founded in 1949 and headquartered in Rye Brook, NY, LLS has regions throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.

For additional information, visit lls.org/lls-newsnetwork. Follow us on Facebook, X, Instagram, LinkedIn and TikTok.

SOURCE The Leukemia & Lymphoma Society (LLS)

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

The Leukemia & Lymphoma Society Announces National Winners of 'Visionaries of the Year' Campaign

The Leukemia & Lymphoma Society Announces National Winners of 'Visionaries of the Year' Campaign

The Leukemia & Lymphoma Society (LLS), the global leader and innovator in creating a world without blood cancer, has concluded its 2025 Visionaries...

The Leukemia & Lymphoma Society Unveils Name Change to Reach All Blood Cancer Patients

The Leukemia & Lymphoma Society Unveils Name Change to Reach All Blood Cancer Patients

The Leukemia & Lymphoma Society (LLS), the global nonprofit in funding blood cancer research, patient support and advocacy, is becoming Blood Cancer...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Personnel Announcements

Personnel Announcements

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.